233 related articles for article (PubMed ID: 27343631)
21. Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.
Seo MS; Park SB; Kang KS
Cell Transplant; 2012; 21(7):1493-502. PubMed ID: 22732242
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.
Margossian T; Reppel L; Makdissy N; Stoltz JF; Bensoussan D; Huselstein C
Biomed Mater Eng; 2012; 22(4):243-54. PubMed ID: 22785368
[TBL] [Abstract][Full Text] [Related]
23. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
Zhang L; Zhao YH; Guan Z; Ye JS; de Isla N; Stoltz JF
Biomed Mater Eng; 2015; 25(1 Suppl):137-43. PubMed ID: 25538064
[TBL] [Abstract][Full Text] [Related]
24. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.
Arno AI; Amini-Nik S; Blit PH; Al-Shehab M; Belo C; Herer E; Jeschke MG
Stem Cells Transl Med; 2014 Mar; 3(3):299-307. PubMed ID: 24436441
[TBL] [Abstract][Full Text] [Related]
25. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
26. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
Hendijani F; Javanmard SH; Sadeghi-aliabadi H
Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
[TBL] [Abstract][Full Text] [Related]
27. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
[TBL] [Abstract][Full Text] [Related]
28. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
[TBL] [Abstract][Full Text] [Related]
29. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
[TBL] [Abstract][Full Text] [Related]
30. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.
Gauthaman K; Yee FC; Cheyyatraivendran S; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2012 Jun; 113(6):2027-39. PubMed ID: 22275115
[TBL] [Abstract][Full Text] [Related]
31. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC).
Zavala G; Prieto CP; Villanueva AA; Palma V
Stem Cell Res Ther; 2017 Sep; 8(1):203. PubMed ID: 28962669
[TBL] [Abstract][Full Text] [Related]
32. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
[TBL] [Abstract][Full Text] [Related]
33. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
Subramanian A; Shu-Uin G; Kae-Siang N; Gauthaman K; Biswas A; Choolani M; Bongso A; Chui-Yee F
J Cell Biochem; 2012 Jun; 113(6):1886-95. PubMed ID: 22234854
[TBL] [Abstract][Full Text] [Related]
34. In vitro differentiation process of human Wharton's jelly mesenchymal stem cells to male germ cells in the presence of gonadal and non-gonadal conditioned media with retinoic acid.
Amidi F; Ataie Nejad N; Agha Hoseini M; Nayernia K; Mazaheri Z; Yamini N; Saeednia S
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1093-101. PubMed ID: 26427713
[TBL] [Abstract][Full Text] [Related]
35. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
[TBL] [Abstract][Full Text] [Related]
36. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
[TBL] [Abstract][Full Text] [Related]
37. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective Potential and Paracrine Activity of Stromal Vs. Culture-Expanded hMSC Derived from Wharton Jelly under Co-Cultured with Hippocampal Organotypic Slices.
Dabrowska S; Sypecka J; Jablonska A; Strojek L; Wielgos M; Domanska-Janik K; Sarnowska A
Mol Neurobiol; 2018 Jul; 55(7):6021-6036. PubMed ID: 29134515
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration.
Edwards SS; Zavala G; Prieto CP; Elliott M; Martínez S; Egaña JT; Bono MR; Palma V
Angiogenesis; 2014 Oct; 17(4):851-66. PubMed ID: 24728929
[TBL] [Abstract][Full Text] [Related]
40. A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.
El-Demerdash RF; Hammad LN; Kamal MM; El Mesallamy HO
Regen Med; 2015; 10(7):841-55. PubMed ID: 26541176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
